Semaglutide
One GLP-1 receptor pathway.
View product guide →Medical weight loss
Compare mechanisms, safety, and what independent clinical review should include. All Livozo care paths are coming soon—not live care today.
One GLP-1 receptor pathway.
View product guide →Dual GIP and GLP-1 receptor pathways.
View product guide →A lower-dose partner-catalog concept; exact fit is a clinician decision.
View product guide →Safety first
Compounded GLP-1 medicines are not FDA-approved and are not generic equivalents of Wegovy, Ozempic, Zepbound, or Mounjaro. A partner clinician and licensed pharmacy—not Livozo—make clinical and dispensing decisions.